PACS Group Q3 revenue beats on higher occupancy rates

Overview

• U.S. post-acute care provider's Q3 revenue rose 11.5%, beating analyst expectations

• Adjusted EPS for Q3 increased 37% year-over-year

• Company raised full-year 2026 revenue and adjusted EBITDA guidance

Outlook

• PACS raises 2026 adj EBITDA outlook to $685 mln-$695 mln from $640 mln-$660 mln

• Company lifts 2026 revenue forecast to $5.95 bln-$6.05 bln from $5.75 bln-$5.85 bln

• Company says acquisition pipeline remains robust and it is actively evaluating new transactions

Result Drivers

• OCCUPANCY AND SKILLED MIX - Co said higher occupancy rates and improved skilled mix contributed to revenue growth

• EXPANSION - Co attributed growth to recent acquisitions in Florida and Texas

• OPERATING EXECUTION - CFO said disciplined operating execution helped translate revenue growth into stronger profitability

Company press release:

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy"

• Wall Street's median 12-month price target for PACS Group, Inc. is $60.00, about 31.6% above its November 2 closing price of $45.58

• The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 20 three months ago

Reuters Recommended Reads

• Nov 2 - Diversified Healthcare Trust Q3 net loss narrows amid occupancy growth

• Nov 2 - Sabra Health Care REIT Q3 revenue rises year-over-year

• Nov 3 - AdaptHealth posts Q3 loss due to goodwill impairment charge

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)